Anti-Mouse E-Cadherin/CD324 Antibody (DECMA-1)

Anti-Mouse E-Cadherin/CD324 Antibody (DECMA-1) 是一种抗小鼠的 E-Cadherin/CD324 IgG1 单克隆抗体,可下调 HER 信号轴和 PI3K/Akt/mTOR 信号通路,抑制肿瘤细胞增殖并诱导其凋亡 (apoptosis),可用于研究癌症和炎症疾病,如癌症、慢性压迫损伤 (CCI) 和哮喘。
Anti-Mouse E-Cadherin/CD324 Antibody (DECMA-1)
产品编号: MS-N12712 分子量: 150 kDa
MolStrong 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务
规格 价格 是否有货 数量 购物车
1mg
询价
询价
5mg
询价
询价
10mg
询价
询价

产品描述

Anti-Mouse E-Cadherin/CD324 Antibody (DECMA-1) 是一种抗小鼠的 E-Cadherin/CD324 IgG1 单克隆抗体,可下调 HER 信号轴和 PI3K/Akt/mTOR 信号通路,抑制肿瘤细胞增殖并诱导其凋亡 (apoptosis),可用于研究癌症和炎症疾病,如癌症、慢性压迫损伤 (CCI) 和哮喘。

生物实验数据

生物活性 Anti-Mouse E-Cadherin/CD324 Antibody (DECMA-1) is an anti-mouse E-Cadherin/CD324 IgG1 monoclonal antibody that downregulates the HER signaling axis and the PI3K/Akt/mTOR signaling pathway, inhibits tumor cell proliferation and induces apoptosis, and can be used for research on cancer and inflammatory diseases such as cancer, chronic constriction injury (CCI), and asthma.
IC50 & Target

Akt

 

mTOR

 

HER1

 

HER2

 

HER3

 

HER4

 

体外研究
(In Vitro)

Anti-Mouse E-Cadherin/CD324 Antibody (DECMA-1) (20 或 400 µg/mL,48 小时) 显著抑制 MCF-7 和 BT474 耐药 (Trastuzumab) (MS-U55108) 细胞系的细胞增殖并诱导其凋亡。
Anti-Mouse E-Cadherin/CD324 Antibody (DECMA-1) 下调 MCF-7 细胞中的 HER (HER1、HER2、HER3 和 HER4) 信号轴和 PI3K/Akt/mTOR 信号通路 (pERK1/2、pAkt、pmTOR、pRaptor 和 p4E-BP1)。

Cell Viability Assay

Cell Line: MCF-7 and BT474-TtzmR cells
Concentration: 20 or 400 µg/mL
Incubation Time: 48 h
Result: Significantly reduced the number of surviving cells.

ELISA Assay

Cell Line: MCF-7 and BT474-TtzmR cells
Concentration: 20 or 400 µg/mL
Incubation Time: 48 h
Result: Significantly increased the number of apoptotic cells.
体内研究
(In Vivo)

Anti-Mouse E-Cadherin/CD324 Antibody (DECMA-1) (1 mg/kg,腹腔注射,每周一次,从年龄 47 天至 90 天) 显著延迟具有自发性乳腺癌症模型的雌性 MMTV-PyMT 小鼠中肿瘤的发生。
Anti-Mouse E-Cadherin/CD324 Antibody (DECMA-1) (1 μg,鞘内注射,每天一次,持续 14 天) 可以逆转胶质细胞源性神经营养因子 (GDNF) 对慢性压迫损伤 (CCI) 模型雄性 C57BL/6 小鼠的镇痛作用。
Anti-Mouse E-Cadherin/CD324 Antibody (DECMA-1) (10 mg/kg,腹腔注射,单次剂量,第二次刺激后 30 分钟或第一次 OVA 刺激后 30 分钟) 显著降低了 Toluene diisocyanate (TDI) 或 OVA (MS-Q48215)/CFA (MS-E83942) 诱导的哮喘模型中雄性 BALB/c 小鼠的炎症反应。

Animal Model: Female MMTV-PyMT mice with a spontaneous breast cancer model
Dosage: 1 mg/kg
Administration: Intraperitoneal injection (i.p.), once a week, from 47 to 90 days of age
Result: Significantly reduced the number and volume of tumors.
Inhibited the proliferation of tumor cells and induced apoptosis.
Downregulated HER1-4 receptors and their downstream signaling molecules (such as pAkt, pmTOR, survivor).
Was non-toxic to normal tissues.
Animal Model: Male C57BL/6 mice (20-25 g) with a chronic compression injury (CCI) model caused by surgery
Dosage: 1 μg
Administration: Intrathecal injection, once daily, for 14 days
Result: Significantly inhibited the analgesic effect of GDNF.
Blocked the regulation of the E-cadherin/p120ctn signaling pathway by GDNF.
Animal Model: Toluene diisocyanate (TDI) or OVA/CFA induced male BALB/c mice (6-8 weeks, 20 g)
Dosage: 10 mg/kg
Administration: Intraperitoneal injection (i.p.), single dose, 30 min after the second stimulation or 30 min after the first OVA challenge
Result: Significantly reduced sE cadherin levels in bronchoalveolar lavage fluid (BALF).
Reduced inflammatory cell infiltration, airway hyperresponsiveness (AHR), and smooth muscle thickening.
Had no effect on goblet cell metaplasia.

化学信息

分子量 150 kDa

储存&溶解度

储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.

计算器

质量 (mg) = 浓度 (mM) x 体积 (mL) x 分子摩尔量 (g/mol)
Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)
起始浓度(M)× 起始体积(L)= 最终浓度(M)× 最终体积(L)
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
This equation is commonly abbreviated as: C1V1 = C2V2
溶液体积 = 质量 ÷ 配液浓度
Volume (to add to vial) = Mass (in vial) ÷ Desired Reconstitution Concentration
÷
分子量计算器
Enter the chemical formula of the compound to calculate its molar mass and elemental composition
g/mol

体内实验配液计算器

动物实验计算换算器

请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法:

比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL, 一共给药动物10只,您使用的配方为 10% DMSO + 40% PEG300 + 5% Tween 80 + 45% Saline / PBS / ddH2O, 那么您的工作液浓度为2 mg/mL。

母液配置方法:2 mg 药物溶于 100 μL DMSO ( 母液浓度为 20 mg/mL ), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。

体内配方的制备方法: 取 100 μL DMSO 母液, 添加 400 μL PEG300 混匀澄清, 再加 50 μL Tween 80, 混匀澄清, 再加 450 μL Saline / PBS / ddH2O 混匀澄清

以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。

方案所需的各类助溶剂如: DMSO, PEG300, PEG400, Tween 80, SBE-β-CD, 玉米油等, 均可在MolStrong网站点击购买。

第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量)
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系客服为您提供正确的澄清溶液配方)
+
+
+

计算结果:

工作液浓度: mg/ml;

DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,

体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL Saline/PBS/ddH2O,混匀澄清。

1. 首先保证母液是澄清的;
           2. 一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。

开始您的科研之旅

20,0000+ 种高纯度分子化合物,专业靶点数据库,全程技术支持
让每一个实验数据都有坚实的分子基础